Drug Approval Package

Exelon (Rivastigmine Tartrate) Solution
Company:  Novartis Pharmaceuticals Corporation
Application No.:  21-025
Approval Date: 4/21/2000

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s) (PDF)  

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) 
  Part 1 (PDF)  
  Part 2 (PDF)  

• Administrative Document(s) & Correspondence (PDF)

Date created: April 11, 2002

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.